---
title: "Indaptus Therapeutics sells 20,000,000 shares at $0.6 in $12 million private placement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290733216.md"
description: "Indaptus Therapeutics completed a private placement of 20 million common shares at $0.60 each, raising approximately $12 million in gross proceeds. The transaction closed on June 17, 2026, targeting non-U.S. accredited investors under Regulation S with no commissions paid. Investors received resale registration rights, with a registration statement due within 90 days and effectiveness targeted within 75 days of filing."
datetime: "2026-06-24T20:02:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290733216.md)
  - [en](https://longbridge.com/en/news/290733216.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290733216.md)
---

# Indaptus Therapeutics sells 20,000,000 shares at $0.6 in $12 million private placement

-   Indaptus Therapeutics priced a private placement of 20,000,000 common shares at USD 0.6 each. \* Gross proceeds totaled about USD 12 million; no commissions were paid. \* Transaction closed June 17, 2026; shares sold to non-U.S. accredited investors in an unregistered offering under Regulation S. \* Investors received resale registration rights; a registration statement is due within 90 days, effectiveness targeted within 75 days of filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indaptus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-029918), on June 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [INDP.US](https://longbridge.com/en/quote/INDP.US.md)

## Related News & Research

- [Indaptus Therapeutics Announces Major Leadership and Board Changes](https://longbridge.com/en/news/280372192.md)
- [Insider Traders Lose US$34k As Indaptus Therapeutics Drops](https://longbridge.com/en/news/292064306.md)
- [Dolfines announces availability of H1 2026 revenue report](https://longbridge.com/en/news/294233994.md)
- [Myriad Genetics rebuilt its AI platform after costs ballooned. Now, it can process documents in seconds.](https://longbridge.com/en/news/293976476.md)
- [Veritone Adds Document Redaction to Create an All-in-One, AI-Powered Redaction Suite | VERI Stock News](https://longbridge.com/en/news/294363244.md)